Pet Pharmaceuticals Industry Research Report 2023
Pet pharmaceutical refers specifically to medicines given to pets.
In terms of the purpose of use, pet drugs are mainly used by dogs and cats. Through drug prevention and treatment of pet diseases, the cure rate of pet diseases can be improved, the physical and mental health of pets can be guaranteed, and the quality of life of pets can be improved.
In terms of clinical significance, the application of pet drugs can provide clinical data for the research and development of new pet drugs, and promote the replacement and upgrading of new pet drugs.
Highlights
The global Pet Pharmaceuticals market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The major players in global Pet Pharmaceuticals market include Zoetis, Boehringer Ingelheim, Merck, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Antiparasitic is the main type, with a share about 30%. Prevention is the main application, which holds a share about 80%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pet Pharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Pharmaceuticals.
The Pet Pharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pet Pharmaceuticals market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Pharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Chopperlvya Animal Health
CAHIC
Product Type Insights
Global markets are presented by Pet Pharmaceuticals type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Pet Pharmaceuticals are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Pet Pharmaceuticals segment by Type
Antiparasitic
Biological Products
Antibacterial
Others
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Pet Pharmaceuticals market and what implications these may have on the industrys future. This report can help to understand the relevant market and consumer trends that are driving the Pet Pharmaceuticals market.
Pet Pharmaceuticals segment by Application
Prevention
Treatment
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Pet Pharmaceuticals market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Pharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Pet Pharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Pet Pharmaceuticals industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Pharmaceuticals.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pet Pharmaceuticals manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pet Pharmaceuticals by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pet Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?
In terms of the purpose of use, pet drugs are mainly used by dogs and cats. Through drug prevention and treatment of pet diseases, the cure rate of pet diseases can be improved, the physical and mental health of pets can be guaranteed, and the quality of life of pets can be improved.
In terms of clinical significance, the application of pet drugs can provide clinical data for the research and development of new pet drugs, and promote the replacement and upgrading of new pet drugs.
Highlights
The global Pet Pharmaceuticals market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The major players in global Pet Pharmaceuticals market include Zoetis, Boehringer Ingelheim, Merck, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Antiparasitic is the main type, with a share about 30%. Prevention is the main application, which holds a share about 80%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pet Pharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Pharmaceuticals.
The Pet Pharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pet Pharmaceuticals market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Pharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Chopperlvya Animal Health
CAHIC
Product Type Insights
Global markets are presented by Pet Pharmaceuticals type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Pet Pharmaceuticals are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Pet Pharmaceuticals segment by Type
Antiparasitic
Biological Products
Antibacterial
Others
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Pet Pharmaceuticals market and what implications these may have on the industrys future. This report can help to understand the relevant market and consumer trends that are driving the Pet Pharmaceuticals market.
Pet Pharmaceuticals segment by Application
Prevention
Treatment
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Pet Pharmaceuticals market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Pharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Pet Pharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Pet Pharmaceuticals industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Pharmaceuticals.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pet Pharmaceuticals manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pet Pharmaceuticals by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pet Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Pet Pharmaceuticals Market Size (2018-2029) & (US$ Million)
2.2.2 Global Pet Pharmaceuticals Sales (2018-2029)
2.2.3 Global Pet Pharmaceuticals Market Average Price (2018-2029)
2.3 Pet Pharmaceuticals by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Antiparasitic
1.2.3 Biological Products
1.2.4 Antibacterial
1.2.5 Others
2.4 Pet Pharmaceuticals by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Prevention
2.4.3 Treatment
3 Market Competitive Landscape by Manufacturers
3.1 Global Pet Pharmaceuticals Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Pet Pharmaceuticals Sales (K Units) of Manufacturers (2018-2023)
3.3 Global Pet Pharmaceuticals Revenue of Manufacturers (2018-2023)
3.4 Global Pet Pharmaceuticals Average Price by Manufacturers (2018-2023)
3.5 Global Pet Pharmaceuticals Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Pet Pharmaceuticals, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Pet Pharmaceuticals, Product Type & Application
3.8 Global Manufacturers of Pet Pharmaceuticals, Date of Enter into This Industry
3.9 Global Pet Pharmaceuticals Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Zoetis
4.1.1 Zoetis Company Information
4.1.2 Zoetis Business Overview
4.1.3 Zoetis Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Zoetis Pet Pharmaceuticals Product Portfolio
4.1.5 Zoetis Recent Developments
4.2 Boehringer Ingelheim
4.2.1 Boehringer Ingelheim Company Information
4.2.2 Boehringer Ingelheim Business Overview
4.2.3 Boehringer Ingelheim Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Boehringer Ingelheim Pet Pharmaceuticals Product Portfolio
4.2.5 Boehringer Ingelheim Recent Developments
4.3 Merck
4.3.1 Merck Company Information
4.3.2 Merck Business Overview
4.3.3 Merck Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Merck Pet Pharmaceuticals Product Portfolio
4.3.5 Merck Recent Developments
4.4 Elanco
4.4.1 Elanco Company Information
4.4.2 Elanco Business Overview
4.4.3 Elanco Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Elanco Pet Pharmaceuticals Product Portfolio
4.4.5 Elanco Recent Developments
4.5 Virbac
4.5.1 Virbac Company Information
4.5.2 Virbac Business Overview
4.5.3 Virbac Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Virbac Pet Pharmaceuticals Product Portfolio
6.5.5 Virbac Recent Developments
4.6 Dechra Veterinary Products
4.6.1 Dechra Veterinary Products Company Information
4.6.2 Dechra Veterinary Products Business Overview
4.6.3 Dechra Veterinary Products Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Dechra Veterinary Products Pet Pharmaceuticals Product Portfolio
4.6.5 Dechra Veterinary Products Recent Developments
4.7 Ceva
4.7.1 Ceva Company Information
4.7.2 Ceva Business Overview
4.7.3 Ceva Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Ceva Pet Pharmaceuticals Product Portfolio
4.7.5 Ceva Recent Developments
6.8 Vetoquinol
4.8.1 Vetoquinol Company Information
4.8.2 Vetoquinol Business Overview
4.8.3 Vetoquinol Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Vetoquinol Pet Pharmaceuticals Product Portfolio
4.8.5 Vetoquinol Recent Developments
4.9 Ouro Fino Saude
4.9.1 Ouro Fino Saude Company Information
4.9.2 Ouro Fino Saude Business Overview
4.9.3 Ouro Fino Saude Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Ouro Fino Saude Pet Pharmaceuticals Product Portfolio
4.9.5 Ouro Fino Saude Recent Developments
4.10 Norbrook
4.10.1 Norbrook Company Information
4.10.2 Norbrook Business Overview
4.10.3 Norbrook Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Norbrook Pet Pharmaceuticals Product Portfolio
4.10.5 Norbrook Recent Developments
6.11 Jindun
6.11.1 Jindun Company Information
6.11.2 Jindun Pet Pharmaceuticals Business Overview
6.11.3 Jindun Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Jindun Pet Pharmaceuticals Product Portfolio
6.11.5 Jindun Recent Developments
6.12 Chopperlvya Animal Health
6.12.1 Chopperlvya Animal Health Company Information
6.12.2 Chopperlvya Animal Health Pet Pharmaceuticals Business Overview
6.12.3 Chopperlvya Animal Health Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Chopperlvya Animal Health Pet Pharmaceuticals Product Portfolio
6.12.5 Chopperlvya Animal Health Recent Developments
6.13 CAHIC
6.13.1 CAHIC Company Information
6.13.2 CAHIC Pet Pharmaceuticals Business Overview
6.13.3 CAHIC Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.13.4 CAHIC Pet Pharmaceuticals Product Portfolio
6.13.5 CAHIC Recent Developments
5 Global Pet Pharmaceuticals Market Scenario by Region
5.1 Global Pet Pharmaceuticals Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Pet Pharmaceuticals Sales by Region: 2018-2029
5.2.1 Global Pet Pharmaceuticals Sales by Region: 2018-2023
5.2.2 Global Pet Pharmaceuticals Sales by Region: 2024-2029
5.3 Global Pet Pharmaceuticals Revenue by Region: 2018-2029
5.3.1 Global Pet Pharmaceuticals Revenue by Region: 2018-2023
5.3.2 Global Pet Pharmaceuticals Revenue by Region: 2024-2029
5.4 North America Pet Pharmaceuticals Market Facts & Figures by Country
5.4.1 North America Pet Pharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Pet Pharmaceuticals Sales by Country (2018-2029)
5.4.3 North America Pet Pharmaceuticals Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Pet Pharmaceuticals Market Facts & Figures by Country
5.5.1 Europe Pet Pharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Pet Pharmaceuticals Sales by Country (2018-2029)
5.5.3 Europe Pet Pharmaceuticals Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Pet Pharmaceuticals Market Facts & Figures by Country
5.6.1 Asia Pacific Pet Pharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Pet Pharmaceuticals Sales by Country (2018-2029)
5.6.3 Asia Pacific Pet Pharmaceuticals Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Pet Pharmaceuticals Market Facts & Figures by Country
5.7.1 Latin America Pet Pharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Pet Pharmaceuticals Sales by Country (2018-2029)
5.7.3 Latin America Pet Pharmaceuticals Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Pet Pharmaceuticals Market Facts & Figures by Country
5.8.1 Middle East and Africa Pet Pharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Pet Pharmaceuticals Sales by Country (2018-2029)
5.8.3 Middle East and Africa Pet Pharmaceuticals Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Pet Pharmaceuticals Sales by Type (2018-2029)
6.1.1 Global Pet Pharmaceuticals Sales by Type (2018-2029) & (K Units)
6.1.2 Global Pet Pharmaceuticals Sales Market Share by Type (2018-2029)
6.2 Global Pet Pharmaceuticals Revenue by Type (2018-2029)
6.2.1 Global Pet Pharmaceuticals Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Pet Pharmaceuticals Revenue Market Share by Type (2018-2029)
6.3 Global Pet Pharmaceuticals Price by Type (2018-2029)
7 Segment by Application
7.1 Global Pet Pharmaceuticals Sales by Application (2018-2029)
7.1.1 Global Pet Pharmaceuticals Sales by Application (2018-2029) & (K Units)
7.1.2 Global Pet Pharmaceuticals Sales Market Share by Application (2018-2029)
7.2 Global Pet Pharmaceuticals Revenue by Application (2018-2029)
6.2.1 Global Pet Pharmaceuticals Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Pet Pharmaceuticals Revenue Market Share by Application (2018-2029)
7.3 Global Pet Pharmaceuticals Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Pet Pharmaceuticals Value Chain Analysis
8.1.1 Pet Pharmaceuticals Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Pet Pharmaceuticals Production Mode & Process
8.2 Pet Pharmaceuticals Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Pet Pharmaceuticals Distributors
8.2.3 Pet Pharmaceuticals Customers
9 Global Pet Pharmaceuticals Analyzing Market Dynamics
9.1 Pet Pharmaceuticals Industry Trends
9.2 Pet Pharmaceuticals Industry Drivers
9.3 Pet Pharmaceuticals Industry Opportunities and Challenges
9.4 Pet Pharmaceuticals Industry Restraints
10 Report Conclusion
11 Disclaimer
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Pet Pharmaceuticals Market Size (2018-2029) & (US$ Million)
2.2.2 Global Pet Pharmaceuticals Sales (2018-2029)
2.2.3 Global Pet Pharmaceuticals Market Average Price (2018-2029)
2.3 Pet Pharmaceuticals by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Antiparasitic
1.2.3 Biological Products
1.2.4 Antibacterial
1.2.5 Others
2.4 Pet Pharmaceuticals by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Prevention
2.4.3 Treatment
3 Market Competitive Landscape by Manufacturers
3.1 Global Pet Pharmaceuticals Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Pet Pharmaceuticals Sales (K Units) of Manufacturers (2018-2023)
3.3 Global Pet Pharmaceuticals Revenue of Manufacturers (2018-2023)
3.4 Global Pet Pharmaceuticals Average Price by Manufacturers (2018-2023)
3.5 Global Pet Pharmaceuticals Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Pet Pharmaceuticals, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Pet Pharmaceuticals, Product Type & Application
3.8 Global Manufacturers of Pet Pharmaceuticals, Date of Enter into This Industry
3.9 Global Pet Pharmaceuticals Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Zoetis
4.1.1 Zoetis Company Information
4.1.2 Zoetis Business Overview
4.1.3 Zoetis Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Zoetis Pet Pharmaceuticals Product Portfolio
4.1.5 Zoetis Recent Developments
4.2 Boehringer Ingelheim
4.2.1 Boehringer Ingelheim Company Information
4.2.2 Boehringer Ingelheim Business Overview
4.2.3 Boehringer Ingelheim Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Boehringer Ingelheim Pet Pharmaceuticals Product Portfolio
4.2.5 Boehringer Ingelheim Recent Developments
4.3 Merck
4.3.1 Merck Company Information
4.3.2 Merck Business Overview
4.3.3 Merck Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Merck Pet Pharmaceuticals Product Portfolio
4.3.5 Merck Recent Developments
4.4 Elanco
4.4.1 Elanco Company Information
4.4.2 Elanco Business Overview
4.4.3 Elanco Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Elanco Pet Pharmaceuticals Product Portfolio
4.4.5 Elanco Recent Developments
4.5 Virbac
4.5.1 Virbac Company Information
4.5.2 Virbac Business Overview
4.5.3 Virbac Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Virbac Pet Pharmaceuticals Product Portfolio
6.5.5 Virbac Recent Developments
4.6 Dechra Veterinary Products
4.6.1 Dechra Veterinary Products Company Information
4.6.2 Dechra Veterinary Products Business Overview
4.6.3 Dechra Veterinary Products Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Dechra Veterinary Products Pet Pharmaceuticals Product Portfolio
4.6.5 Dechra Veterinary Products Recent Developments
4.7 Ceva
4.7.1 Ceva Company Information
4.7.2 Ceva Business Overview
4.7.3 Ceva Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Ceva Pet Pharmaceuticals Product Portfolio
4.7.5 Ceva Recent Developments
6.8 Vetoquinol
4.8.1 Vetoquinol Company Information
4.8.2 Vetoquinol Business Overview
4.8.3 Vetoquinol Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Vetoquinol Pet Pharmaceuticals Product Portfolio
4.8.5 Vetoquinol Recent Developments
4.9 Ouro Fino Saude
4.9.1 Ouro Fino Saude Company Information
4.9.2 Ouro Fino Saude Business Overview
4.9.3 Ouro Fino Saude Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Ouro Fino Saude Pet Pharmaceuticals Product Portfolio
4.9.5 Ouro Fino Saude Recent Developments
4.10 Norbrook
4.10.1 Norbrook Company Information
4.10.2 Norbrook Business Overview
4.10.3 Norbrook Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Norbrook Pet Pharmaceuticals Product Portfolio
4.10.5 Norbrook Recent Developments
6.11 Jindun
6.11.1 Jindun Company Information
6.11.2 Jindun Pet Pharmaceuticals Business Overview
6.11.3 Jindun Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Jindun Pet Pharmaceuticals Product Portfolio
6.11.5 Jindun Recent Developments
6.12 Chopperlvya Animal Health
6.12.1 Chopperlvya Animal Health Company Information
6.12.2 Chopperlvya Animal Health Pet Pharmaceuticals Business Overview
6.12.3 Chopperlvya Animal Health Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Chopperlvya Animal Health Pet Pharmaceuticals Product Portfolio
6.12.5 Chopperlvya Animal Health Recent Developments
6.13 CAHIC
6.13.1 CAHIC Company Information
6.13.2 CAHIC Pet Pharmaceuticals Business Overview
6.13.3 CAHIC Pet Pharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.13.4 CAHIC Pet Pharmaceuticals Product Portfolio
6.13.5 CAHIC Recent Developments
5 Global Pet Pharmaceuticals Market Scenario by Region
5.1 Global Pet Pharmaceuticals Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Pet Pharmaceuticals Sales by Region: 2018-2029
5.2.1 Global Pet Pharmaceuticals Sales by Region: 2018-2023
5.2.2 Global Pet Pharmaceuticals Sales by Region: 2024-2029
5.3 Global Pet Pharmaceuticals Revenue by Region: 2018-2029
5.3.1 Global Pet Pharmaceuticals Revenue by Region: 2018-2023
5.3.2 Global Pet Pharmaceuticals Revenue by Region: 2024-2029
5.4 North America Pet Pharmaceuticals Market Facts & Figures by Country
5.4.1 North America Pet Pharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Pet Pharmaceuticals Sales by Country (2018-2029)
5.4.3 North America Pet Pharmaceuticals Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Pet Pharmaceuticals Market Facts & Figures by Country
5.5.1 Europe Pet Pharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Pet Pharmaceuticals Sales by Country (2018-2029)
5.5.3 Europe Pet Pharmaceuticals Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Pet Pharmaceuticals Market Facts & Figures by Country
5.6.1 Asia Pacific Pet Pharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Pet Pharmaceuticals Sales by Country (2018-2029)
5.6.3 Asia Pacific Pet Pharmaceuticals Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Pet Pharmaceuticals Market Facts & Figures by Country
5.7.1 Latin America Pet Pharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Pet Pharmaceuticals Sales by Country (2018-2029)
5.7.3 Latin America Pet Pharmaceuticals Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Pet Pharmaceuticals Market Facts & Figures by Country
5.8.1 Middle East and Africa Pet Pharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Pet Pharmaceuticals Sales by Country (2018-2029)
5.8.3 Middle East and Africa Pet Pharmaceuticals Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Pet Pharmaceuticals Sales by Type (2018-2029)
6.1.1 Global Pet Pharmaceuticals Sales by Type (2018-2029) & (K Units)
6.1.2 Global Pet Pharmaceuticals Sales Market Share by Type (2018-2029)
6.2 Global Pet Pharmaceuticals Revenue by Type (2018-2029)
6.2.1 Global Pet Pharmaceuticals Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Pet Pharmaceuticals Revenue Market Share by Type (2018-2029)
6.3 Global Pet Pharmaceuticals Price by Type (2018-2029)
7 Segment by Application
7.1 Global Pet Pharmaceuticals Sales by Application (2018-2029)
7.1.1 Global Pet Pharmaceuticals Sales by Application (2018-2029) & (K Units)
7.1.2 Global Pet Pharmaceuticals Sales Market Share by Application (2018-2029)
7.2 Global Pet Pharmaceuticals Revenue by Application (2018-2029)
6.2.1 Global Pet Pharmaceuticals Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Pet Pharmaceuticals Revenue Market Share by Application (2018-2029)
7.3 Global Pet Pharmaceuticals Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Pet Pharmaceuticals Value Chain Analysis
8.1.1 Pet Pharmaceuticals Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Pet Pharmaceuticals Production Mode & Process
8.2 Pet Pharmaceuticals Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Pet Pharmaceuticals Distributors
8.2.3 Pet Pharmaceuticals Customers
9 Global Pet Pharmaceuticals Analyzing Market Dynamics
9.1 Pet Pharmaceuticals Industry Trends
9.2 Pet Pharmaceuticals Industry Drivers
9.3 Pet Pharmaceuticals Industry Opportunities and Challenges
9.4 Pet Pharmaceuticals Industry Restraints
10 Report Conclusion
11 Disclaimer